NCT00216606View on ClinicalTrials.gov

The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine

PHASE3CompletedINTERVENTIONAL

Enrollment

59

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

July 31, 2005

Conditions

Migraine

Interventions

DRUG

topiramate

All Listed Sponsors

lead

Janssen Pharmaceutica N.V., Belgium

INDUSTRY

NCT00216606 - The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine | Biotech Hunter | Biotech Hunter